Page last updated: 2024-09-05

enzastaurin and Uveal Neoplasms

enzastaurin has been researched along with Uveal Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fletcher, JA; Giobbie-Hurder, A; Hodi, FS; Wu, X; Zhu, M1

Other Studies

1 other study(ies) available for enzastaurin and Uveal Neoplasms

ArticleYear
The protein kinase C inhibitor enzastaurin exhibits antitumor activity against uveal melanoma.
    PloS one, 2012, Volume: 7, Issue:1

    Topics: Apoptosis; Bromodeoxyuridine; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p27; Drug Screening Assays, Antitumor; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; GTP-Binding Protein alpha Subunits; GTP-Binding Protein alpha Subunits, Gq-G11; Humans; Indoles; Isoenzymes; Melanoma; Mitogen-Activated Protein Kinase Kinases; Molecular Sequence Data; Mutation; Protein Kinase C; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Uveal Neoplasms

2012